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Abstract
Maternal drug abuse during pregnancy is a rapidly escalating soci-
etal problem. Psychostimulants, including amphetamine, cocaine,
and methamphetamine, are amongst the illicit drugs most
commonly consumed by pregnant women. Neuropharmacology
concepts posit that psychostimulants affect monoamine signaling
in the nervous system by their affinities to neurotransmitter reup-
take and vesicular transporters to heighten neurotransmitter
availability extracellularly. Exacerbated dopamine signaling is
particularly considered as a key determinant of psychostimulant
action. Much less is known about possible adverse effects of these
drugs on peripheral organs, and if in utero exposure induces life-
long pathologies. Here, we addressed this question by combining
human RNA-seq data with cellular and mouse models of neuroen-
docrine development. We show that episodic maternal exposure to
psychostimulants during pregnancy coincident with the intrauter-
ine specification of pancreatic b cells permanently impairs their
ability of insulin production, leading to glucose intolerance in adult
female but not male offspring. We link psychostimulant action
specifically to serotonin signaling and implicate the sex-specific
epigenetic reprogramming of serotonin-related gene regulatory
networks upstream from the transcription factor Pet1/Fev as
determinants of reduced insulin production.
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Introduction
The misuse of psychostimulants is a major socioeconomic burden,
affecting up to 50 million people worldwide (Oliere et al, 2013).
Population analyses show that 5.4% of pregnant females aged
between 15 and 44 years abuse illicit drugs, highlighting fetal expo-
sures as a significant public concern (Substance Abuse and Mental
Health Services Administration, 2014). Amphetamine, cocaine, and
methamphetamine are the most commonly consumed psychostimu-
lants with their peripheral effects mimicking the activation of the
sympathetic nervous system: increased heart rate and blood pres-
sure, decreased digestion, and mobilization of glucose reserves
(Favrod-Coune & Broers, 2010). Their mechanism of action centers
on molecular interference with monoamine reuptake transporters
(i.e., reversal of substrate flow) (Howell & Negus, 2014; Ross et al,
2015) and/or inhibition of monoamine oxidases. Consequently,
extracellular concentrations of dopamine (DA), norepinephrine
(NE), and serotonin (5-HT) surge, which prolongs their action on
respective receptor systems (Kitanaka et al, 2006; Ross et al, 2015;
Liu et al, 2016).
Amphetamine, cocaine, and methamphetamine can cross the
placenta to directly affect the developing fetus (Thompson et al,
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2009). Given their potent action on brain function and develop-
ment (Ross et al, 2015), the bulk of available literature focuses
on psychostimulant effects on the behavior and cognition of
affected offspring (Middaugh, 1989; Diaz et al, 2014; Volkow &
Morales, 2015; Martin et al, 2016). Even though a link between
prenatal psychostimulant exposure and an increased risk for the
offspring to develop type 2 diabetes has been noted and asso-
ciated with maternal malnutrition (Vaiserman, 2015), data on the
psychostimulant-induced priming of glucose metabolism to render
affected offspring glucose intolerant are lacking. This is unex-
pected because endocrine cells of the pancreas are programmed
during embryonic and early postnatal periods and, consequently,
only commence hormone secretion postnatally (Murtaugh, 2007).
Thus, disrupted cellular turnover and inter- or intracellular signal-
ing for terminal differentiation during intrauterine development
carries the risk of lifelong impairments of bodily energy home-
ostasis.
DA, NE, and 5-HT signaling regulate secretory functions of the
endocrine pancreas. DA and its precursor L-dopa inhibit glucose-
stimulated insulin secretion (Ustione & Piston, 2012). NE released
from innervating sympathetic nerves shapes islet architecture and
inhibits insulin but promotes glucagon release (Sorenson et al,
1979; Borden et al, 2013). 5-HT is proposed to function as a para-
crine signal stimulating b cell proliferation and insulin release,
while inhibiting glucagon secretion (Paulmann et al, 2009; Kim
et al, 2010; Almaca et al, 2016). 5-HT action on b cells converges
on Pet1 (alternative name: Fev), an E-twenty-six (ETS) transcrip-
tion factor that, in analogy to being a “master transcriptional regu-
lator” of 5-HT programs in neurons (Bonnin & Levitt, 2011),
induces insulin (Ins1/2) expression in a mechanism downstream
from, e.g., 5-HT1A (Htr1a) receptors (Ohta et al, 2011). Therefore,
we hypothesized that fetal b cell programming by monoamines,
particularly 5-HT, can be susceptible to maternal psychostimulant
abuse with adverse effects enduring into the adulthood of affected
offspring.
Here, we interrogated data from RNA-seq of the fetal human
pancreas with support from single-cell RNA-seq of human a and b
cells to show a molecularly complete (cell-autonomous) metabolic
loop for 5-HT but neither DA nor NE signaling. Accordingly,
b cells express both SLC18A2 and SLC6A4 (SERT) but not
SLC6A3/SLC6A2, highlighting preferential 5-HT transport as a crit-
ical molecular substrate for psychostimulant action in utero. 5-HT
signaling and uptake operate in both fetal and adult pancreata of
mice and are impaired by psychostimulants. We provide evidence
that psychostimulants acutely reshape b cell excitability in a fash-
ion that is sensitive to competition by escitalopram, a selective
SERT inhibitor. We then find that 5-HT uptake primes protein
serotonylation in a b cell model in vitro, which is eliminated
by psychostimulants, e.g., amphetamine. Subsequently, a lifelong
reduction of 5-HT-driven Pet1/Fev expression is identified, which
correlates with that of insulin and 5-HT in pancreatic b cells
prenatally exposed to psychostimulants. These molecular changes
are sufficient to compromise glucose homeostasis for life with
female offspring in experimental models being more susceptible to
developing pre-diabetic glucose intolerance by adulthood than
males. However, it is neither Pet1/Fev not Ins1/2 itself but
their upstream 5-HT-sensitive gene regulatory networks that
undergo lifelong epigenetic reprogramming in the prenatally
psychostimulant-exposed pancreas. In sum, these data uncover
key molecular determinants of permanent pancreas dysfunction
in offspring from mothers with a history of drug abuse during
pregnancy.
Results
Monoamine signaling in the human fetal pancreas
Given that the widely accepted mechanism of action for psychostim-
ulants is interference with both intracellular vesicular transport and
cell-surface reuptake systems tuning monoamine levels extracellu-
larly (Ross et al, 2015), we first profiled molecular constituents of 5-
HT, DA, and NE signaling in fetal human pancreata (Fig 1). These
data showed mRNA expression for 5-HT receptors (HTR1B, HTR2A/
B/C, HTR3E), the 5-HT reuptake transporter SLC6A4 (SERT), and
tryptophan hydroxylases (particularly TPH1; Fig 1A). During mid-
to-late 1st trimester of pregnancy, the fetal human pancreas also
expresses adrenergic receptors (ADRA2A/2B, ADRA3B), dopamine-
b-hydroxylase (DBH), and more infrequently SLC6A2 (NET), medi-
ating NE reuptake (Fig 1C). Notably, neither dopamine receptors
nor SLC6A3 (DAT) are expressed even if tyrosine hydroxylase (TH)
is detected at varying levels (Fig 1D). Expression of SLC18A2,
encoding the vesicular monoamine transporter (VMAT2), supports
A
C D
B
Figure 1. Monoamine signaling in human fetal pancreas.
A–D RNA-seq of fetal pancreata during gestational weeks 7–14 revealed the
presence (or lack) of molecular determinants for serotonin (A),
epinephrine/norepinephrine (C), and dopamine (D) signaling. Expression
of the vesicular monoamine transporter (SLC18A2; Vmat2), which is non-
selective for monoamines, was plotted separately (B). Data were
expressed as log counts per million mapped reads (logCPM).
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efficient monoamine release (Fig 1B). These data suggest that the
fetal pancreas can produce and release monoamines, in an order of
5-HT ~ NE > DA, with DA signaling being an unlikely target for
psychostimulants given the lack of SLC6A3 expression. However,
this analysis lacks resolution to differentiate between exocrine and
endocrine components.
Therefore, we processed single-cell RNA-seq matrices of dissoci-
ated human a and b cells (Segerstolpe et al, 2016), which showed b
cells to express the 5-HT receptors HTR1F and HTR2B, SLC6A4, and
TPH2 (Fig EV1A). A similar pattern of expression for 5-HT signaling
was also seen in human a cells (Fig EV1B). Human b cells also
express a variety of adrenergic receptors (ADRA1B, ADRA2A,
ADRB1, ADRB2), infrequently DBH but lack SLC6A2 (Fig EV1A1).
Human a cells express ADRB1 and ADRB2 receptors abundantly,
DBH infrequently with SLC6A2 expression being absent
(Fig EV1B1). For DA signaling, b cells express the biosynthesis
enzyme tyrosine hydroxylase (TH) but lack both SLC6A3 and recep-
tors (Fig EV1A2). In contrast, a cells express DRD1 and DRD4 recep-
tors but neither TH nor SLC6A3 (Fig EV1B2). Expression of
SLC18A2 (VMAT2) supports efficient monoamine release from both
b and a cells (Fig EV1A3 and B3). These data are congruent with
our fetal tissue profiling and suggest that pancreatic b and a cells
harbor the capacity of both cell-autonomous and bidirectional para-
crine 5-HT signaling (Almaca et al, 2016). In addition, both cell
types can sense extracellular NE and utilize unidirectional b-to-a cell
communication by DA. Considering that b cells express a functional
5-HT signaling cassette, and 5-HT signaling was previously linked to
b cell proliferation and insulin and glucagon secretion (Paulmann
et al, 2009; Kim et al, 2010; Almaca et al, 2016), we addressed the
organization of 5-HT signaling in the endocrine pancreas of develop-
ing mice. Given the presence of SLC6A4 but not SLC6A2/SLC6A3 in
b cells, this was followed by interrogating psychostimulant-induced
modifications to 5-HT signaling.
5-HT signaling in developing mouse pancreas
To gain insights into the organization of 5-HT signaling in the endo-
crine pancreas, we histochemically sampled mouse tissues at
embryonic day (E)14.5 (which corresponds to the start of the
secondary transition that generates endocrine lineages (Mastracci &
Sussel, 2012)), birth (P0), and adulthood. 5-HT was not detected
and other markers were lowly expressed at E14.5. Therefore, we
have focused on neonatal (P0) and 6-week time points. All molecu-
lar determinants of 5-HT signaling showed a preference toward
expression in insulin-positive(+) b cells (Fig 2A–J1), including
TPH2 (Fig 2A and B1), 5-HT (Fig 2C and D2), SERT (Fig 2E and
F1), 5-HT receptor 1F (5-HTR1F; Fig 2G and H1), and 5-HTR1A
(Fig 2I and J1). The expression of TPH2 and SERT, which were
stably seen in b cells, was also confirmed by qPCR (Appendix Fig
S1A). Even though we tested a number of anti-VMAT2 antibodies,
none of these produced reliable immunohistochemical signals,
which corroborate the reported lack of VMAT2 expression in labora-
tory rodents (Schafer et al, 2013). These data are compatible with
the notion that 5-HT signaling is a critical factor for pancreas devel-
opment (Ohta et al, 2011) and show that 5-HTR1F and 5-HTR1A can
support 5-HT signaling in mice (Almaca et al, 2016).
Next, we used INS-1E cells, an in vitro model of insulin secre-
tion (Asfari et al, 1992; Malenczyk et al, 2013), to test their
responses to 5-HT by Ca2+ imaging particularly since Ca2+ peaks
are considered reliable indicators of glucose-induced b cell
excitability (Bergsten et al, 1994; Fridlyand et al, 2010). In 11 mM
glucose, INS-1E cells were spontaneously active (i.e., they release
insulin through regulated exocytosis; Malenczyk et al, 2017;
Fig 2K). 5-HT in the 100 nM-to-1 lM range induced a dose-depen-
dent reduction of the frequency of Ca2+ oscillations (Fig 2K1). At
the same time, the amplitude of Ca2+ oscillations significantly
increased (Fig 2K1). These data show that INS-1E cells respond to
5-HT bath-applied acutely and suggest that subthreshold and fast
Ca2+ events appear as high-amplitude oscillations by Fura2-AM-
based Ca2+ imaging.
We then asked whether INS-1E cells could also respond to DA
and NE. By using 3H-labeled monoamines, we find considerable 5-
HT but neither DA nor NE uptake (Fig 2L). [3H]5-HT uptake was
significantly inhibited by escitalopram, confirming SERT involve-
ment (Fig 2L). Notably, the level of SERT activity in INS-1E cells
was a magnitude lower than seen in serotonergic neurons in brain
(Ohta et al, 2011). Subsequently, we showed that 5-HT uptake lacks
a reserpine-sensitive component, confirming that VMAT2 is unlikely
to play a role in this uptake mechanism (Fig 2M). These data thus
highlight the preferential use of 5-HT by b cell-like cells and corrob-
orate our and others’ (Schafer et al, 2013) data on the absence of
VMAT2 in rodent b cells. Thus, we suggest a role for 5-HT upon
SERT-mediated uptake as an intracellular precursor rather than a
transmitter directly co-partitioned with insulin into release granules
(Fig 2N).
Psychostimulants induce inward currents upon SERT engagement
and inhibit Ca2+ signaling
The presence of a molecularly intact 5-HT signaling loop in b
cells together with their 5-HT sensitivity suggests that b cells
could be equally sensitive to illicit psychostimulants whose mech-
anism of action centers on SERT inactivation by phosphorylation
and sequestration (Ramamoorthy & Blakely, 1999) and even
reversal of its electrogenic transport (Shi et al, 2008; Robertson
et al, 2009; Sitte & Freissmuth, 2015). Psychostimulants were
previously shown to induce inward currents in neurons and
cultured cell lines (Hilber et al, 2005), which could be explained
by increased intracellular Na+ co-transported by SERT (Robertson
et al, 2009). To confirm this hypothesis, we recorded psychoac-
tive drug effects in HEK293 cells stably expressing the human
SERT (HEK293-SERT) clamped to a holding potential of 70 mV
(Fig 3A). Amphetamine (25 lM), cocaine (10 lM), and metham-
phetamine (5 lM) induced significant inward currents, which
appeared with considerable time-lag for amphetamine and cocaine
and were escitalopram (10 lM)-sensitive (Fig 3A). Escitalopram
alone did not affect the membrane potential of HEK293-SERT cells
(Fig 3A1).
Subsequently, we exposed INS-1E cells to increasing concentra-
tions of the psychostimulants applied acutely by superfusion and
recorded their intracellular Ca2+ responses. INS-1E cells did not
produce spontaneous Ca2+ oscillations in the presence of low
glucose (3 mM; Fig EV2A–D). None of the drugs (amphetamine,
cocaine or methamphetamine) used exerted any effect either
(Fig EV2A–D). In contrast, superfusion of 11 mM glucose induced
Ca2+ oscillations in INS-1E cells with both their frequency and
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amplitude reduced by amphetamine at doses > 10 lM (Fig 3B; see
also Fig EV2A1). Cocaine induced a biphasic effect: up to 10 lM
concentration, it reduced the frequency, but not the amplitude of
Ca2+ waves. At a dose of 100 lM, however, it augmented both the
amplitude and the frequency of Ca2+ oscillations (P < 0.01; Figs 3B
and EV2B1). Methamphetamine effects were reminiscent to those of
amphetamine (at a magnitude lower concentration range;
Fig EV2C1), reducing the frequency of Ca2+ oscillations in a dose-
dependent fashion.
Psychostimulant action could be indirectly mediated by either the
allosteric modulation of 5-HT receptors (Borycz et al, 2008; Zhou &
Cunningham, 2018) or the buildup of extracellular 5-HT and its spil-
lover upon SERT occlusion. Here, we tested whether escalating doses
of escitalopram evoke responses similar to those by the drugs used.
A A1 B B1
K1
L
M
N
C C1
E
G
I I1 J J1
K
H H1
E1 F F1
D D1 D2
Figure 2.
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Indeed, acute escitalopram superfusion of INS-1E cells at 10 lM or
higher concentrations also reduced both the amplitude and
frequency of Ca2+ oscillations (P < 0.05; Figs 3B1 and EV2D1).
We then superfused escitalopram (1 lM) alone or in combina-
tion with the psychostimulants. Because escitalopram binds to the
orthosteric site of SERT, only partially, if at all, overlapping
◀ Figure 2. Serotonin signaling during development of the endocrine pancreas in mouse.A–J All markers are shown at birth (P0) and at 6 weeks of age: (A-B1) tryptophan hydroxylase 2 (TPH2), (C-D2) serotonin (5-HT), (E-F1) serotonin reuptake transporter
(SERT), (G-H1) 5-HT receptor 1F subtype (5-HT1F), and (I-J1) 5-HT1A. Note that all histochemical marks localized to b cells with only sporadic expression, if any, in a
cells. 5-HT was mostly absent in E14.5 pancreata therefore earlier developmental stages are not shown. “Airyscan” (A1) identifies the lack of false-positive co-
localization between TPH2 and insulin at superresolution. Open arrowheads indicate the lack of co-localization between select markers. Solid arrows pinpoint
cellular sites of co-existence for pairs of histochemical marks. Asterisks label the positions of nuclei (A1). Representative images are shown from n ≥ 3 pancreata/age
group. Hoechst 33342 was used as a nuclear counterstain (pseudo-colored in gray). Scale bars = 80 lm (D), 20 lm (A–B1,F–J1), 10 lm (C–E1), and 1 lm (A1).
K Representative Ca2+ signals upon exposure of INS-1E cells pre-loaded with Fura2-AM to 5-HT at the concentrations indicated. Drugs were superfused acutely as
shown. Acetylcholine (ACh, 5 lM) served as positive control. (K1) Quantitative analysis of Ca2+ responses in INS-1E cells to incrementing concentrations of 5-HT.
Data on the frequency (upper) and amplitude (lower) of Ca2+ transients are shown (normalized to baseline).
L Tritiated monoamine uptake in INS-1E cells and its sensitivity to selective SERT and DAT/NET inhibitors.
M 5-HT uptake in INS-1E cells in the presence of increasing extracellular glucose concentrations. Reserpine was used to inhibit VMAT2.
N Schema outlining intracellular signaling and metabolic cascades in fetal b cells for the use of 5-HT taken up through SERT engagement. “Classical” refers to a
neuron-like/adult-like scenario with 5-HT directly loaded into release vesicles by VMAT2 (or a hypothetical alternative transport mechanism).
Data information: Data in (K1–M) were expressed as means  SEM. Red symbols in K1 mark individual observations, that is, biological replicates. ***P < 0.001,
**P < 0.01 (pair-wise comparisons after one-way ANOVA).
A B
A1 B1
Figure 3. Psychostimulants induce electrogenic currents and modulate Ca2+ signaling in INS-1E cells.
A Psychostimulants (A) but not escitalopram (A1) induced inward currents in HEK293 cells transfected with the human serotonin transporter (HEK293-SERT). Note that
escitalopram co-application occluded psychostimulant effects. For each drug, a representative recording trace is shown on the left, while quantitative data
(means  SEM; n > 6/group) are on the right. Note that cocaine effects were short-lived downward deflections, whereas methamphetamine commonly induced
prolonged inward currents that lasted even during washout. HEK293 cells were clamped at 70 mV throughout.
B Amphetamine and methamphetamine reduced both the amplitude and frequency of Ca2+ oscillations in INS-1E cells loaded with Fura-2AM. In contrast, cocaine at
high concentrations increased both parameters measured. Data were normalized to baseline and expressed as means  SEM. Symbols in red denote biological
replicates. (B1) Escitalopram alone also reduced the amplitude and slowed the frequency of Ca2+ oscillations in INS-1E ells. Experiments were performed in the
presence of 11 mM glucose. Acetylcholine (ACh; 5 lM) was used as positive control. Figure EV3 is referred to showing representative Ca2+ recordings for drug
concentrations other than the ones on the left of (B, B1).
Data information: ***P < 0.001, **P < 0.01, *P < 0.05 (pair-wise comparisons after one-way ANOVA).
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(Kristensen et al, 2011) with amphetamine, cocaine, and metham-
phetamine bindings sites, we expected that subthreshold escitalo-
pram doses could sensitize INS-1E cells to psychostimulants.
Indeed, the psychostimulant-induced slowing of Ca2+ oscillations
was significantly augmented by escitalopram (Fig EV3). A rebound
effect was seen for the amplitude of Ca2+ transients in the presence
of 50 lM amphetamine though (Fig EV3A). For cocaine (Fig EV3B)
and methamphetamine (Fig EV3C), however, the amplitudes of
Ca2+ oscillations were reduced in a dose-dependent manner. These
data cumulatively suggest that psychostimulants engage SERT, and
can cooperate with escitalopram to modulate intracellular Ca2+
signaling in INS-1E cells in vitro.
Amphetamine reduces protein serotonylation in vitro
Blockade, and even reversal, of cell-surface transporters mediating
monoamine reuptake (NET, DAT, SERT) is one of the mechanisms
by which psychostimulants enhance extracellular monoamine levels
(Pifl et al, 1995; Steinkellner et al, 2014; Sitte & Freissmuth, 2015).
Therefore, whether SERT is operational in fetal pancreas is of mech-
anistic significance. We addressed this question by preparing
pancreas explants on E13.5 and culturing those for 6 days. To
closely match the in vivo experimental conditions (Appendix Fig
S2), explants were treated with 5-HT (500 nM) daily 1–3 days later,
equivalent to the period of E14.5-16.5. Twenty-four hours after the
last treatment, pancreata were transferred to fresh medium and
cultured for another 2 days. 5-HT accumulated in pancreas explants
as shown by both immunofluorescence cytochemistry (Fig 4A) and
HPLC (in INS-1E cell homogenates 45 min after extracellular 5-HT
(5 lM) loading; Fig 4B) (Pifl et al, 1995). These data demonstrate
that 5-HT uptake mechanisms are likely operational during fetal
development with intracellular 5-HT available over considerable
periods. More broadly, these results suggest that the fetal pancreas
can be sensitive to blood-borne 5-HT produced by the placenta
(from maternal tryptophan precursors) or other maternal sources
(Cote et al, 2007; Bonnin et al, 2011).
We then asked whether intracellular 5-HT retained over
prolonged periods is of functional significance. In INS-1E cells, 5-HT
exposure for 4 h significantly increased the level of proteins that
had incorporated a 5-HT moiety (Fig 4C), indicative of protein
serotonylation. Notably, and regardless of the molecular identity of
the target proteins (note that Rabs were assigned as preferred molec-
ular targets in b cell earlier (Paulmann et al, 2009)), amphetamine
occluded protein serotonylation when co-applied with 5-HT
(Fig 4C). These data reveal that long-lived 5-HT signals in fetal
pancreata might indicate the accumulation of transamidated
proteins covalently incorporating 5-HT during b cell development.
Moreover, they corroborate recent data in Tph1/ mice, which
present disrupted protein serotonylation in the pancreas as part of
their diabetic pathology (Paulmann et al, 2009).
Intrauterine psychostimulant exposure reduces 5-HT and insulin
content in fetal pancreas
We tested the effect of psychostimulants on endocrine pancreas
development in vivo by injecting (i.p.) pregnant dams with amphe-
tamine (10 mg/kg body weight), cocaine (20 mg/kg), metham-
phetamine (10 mg/kg), or saline (as control) once daily between
E14.5 and 16.5 (Fig 4D), corresponding to drug doses commonly
used to disrupt brain development (Lee & O’Dowd, 1999; Khorad-
mehr et al, 2015). None of the pregnancies were aborted, and litter
sizes were not affected by drug treatment [7  2 (metham-
phetamine), 7  1 (amphetamine), 7  1 (cocaine) versus 6  1
(saline)]. At P0, each litter was reduced to 6 pups, which were used
to analyze prenatal drug effects on postnatal glucose metabolism.
Amphetamine, cocaine, and methamphetamine exert cytotoxic
effects in the brain (Zhu et al, 2006; Costa et al, 2013). Therefore,
we first determined the number of b and a cells in P0 pancreata.
None of the drugs reduced either b or a cell numbers (Fig 4D1 and
D2), suggesting that the doses of psychostimulants used did not per
se disrupt pancreas development. Nevertheless, the psychostimu-
lants used significantly reduced intracellular 5-HT content in b cells,
measured immunohistochemically [P < 0.01 (amphetamine),
P < 0.05 (cocaine), P < 0.01 (methamphetamine) versus (saline);
Fig 4D1 and E]. Insulin levels were similarly reduced [P < 0.05 (am-
phetamine), P < 0.01 (cocaine), P < 0.001 (methamphetamine),
versus (saline); Fig 4F]. Since 5-HT is stored in the same granules
as insulin in mature b cells (Lundquist et al, 1971) and protein
serotonylation might be a precursor to insulin production (see
above), we plotted 5-HT versus insulin immunoreactivity per b cell:
all treatments returned significant positive correlation (Fig 4G)
suggesting synchronous regulation of 5-HT and insulin levels. None
of the psychostimulants affected glucagon content in the neonatal
pancreas (Appendix Fig S1B), pinpointing b cells as a locus for
adverse developmental drug effects.
The above observations together with our data from pancreatic
explants would suggest that reduced insulin levels in b cells indi-
cate their delayed development (or permanent inability to produce
insulin; for Ins1 mRNA changes, we refer to Fig EV4B). The
finding that the number of pancreatic and duodenal homeobox 1
(Pdx1)+ cells in P0 pancreata remained unchanged suggests that
they retained the capacity to produce b cells (Fig EV4A). Yet,
reduced levels of neurogenin 3-dependent expression of paired
neuronal differentiation 1 (NeuroD1) and NK6 homeobox 1
(Nkx6.1), late markers of b cell specification (Malenczyk et al,
2018) (Fig EV4B), are suggestive of delayed pancreas maturation
upon preceding amphetamine (and more broadly psychostimu-
lant) action.
Most illicit drugs exhibit gender bias: developmental toxicology
studies show male sensitivity to cannabis (Jutras-Aswad et al,
2009). In contrast, amphetamine seems particularly harmful for
females (Kogachi et al, 2017). Therefore, we tested whether amphe-
tamine exerts a sex-specific effect on b cell development. We found
that pancreatic insulin immunoreactivity was significantly reduced
in female but not male neonates prenatally exposed to amphetamine
(Fig 5A and A1). Glucagon levels, albeit reduced in offspring after
prenatal amphetamine exposure, did not reach statistical signifi-
cance (but see Fig EV4C and C1). When reconstructing neonatal
pancreata by light-sheet microscopy, we find that it is not the
number of islets per se [55.3  11.9 (saline) versus 72.3  17.2
(amphetamine)] but rather their size and insulin immunoreactivity
that seem reduced in prenatally amphetamine-exposed females
(Fig 5B and B1 and Movies EV1 and EV2). It is noteworthy that
both escitalopram (Fig 5A and A1) and genetic deletion of Slc6a4
(Fig EV4C and C1, and Appendix Fig S3) phenocopied amphetamine
effects in female offspring. Cumulatively, these data show that
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pancreas development is sensitive to psychostimulant action in a
sex-specific manner and uses SERT to disrupt insulin production by
b cells.
Prenatal exposure to psychostimulants impairs insulin expression
and leads to glucose intolerance in adult offspring
If viewed as a developmental delay, the fetal deregulation of insulin
production and signaling might be assumed as becoming compen-
sated later in life. Alternatively, psychostimulant effects could
persist throughout postnatal life and sensitize the offspring to devel-
oping glucose intolerance/diabetes. When analyzing 6-week-old
offspring, we find that the number of b and a cells is not affected by
prenatal drug exposure (Appendix Fig S4A). These data are compati-
ble with our ex vivo observations (Fig 4D2), as well as continued b
cell proliferation in postnatal pancreata (Taylor et al, 2015). Never-
theless, examination of sex effects in 6-week-old offspring showed
profoundly reduced insulin immunoreactivity in females (P < 0.05
for all drugs versus saline; Fig 6A and A1) but not males (Fig 6A).
At the same time, glucagon immunoreactivity remained unaffected
A
D
E F G
D1 D2
B C
Figure 4. Psychostimulants reduce protein phosphorylation in vitro and intracellular insulin and serotonin levels in pancreatic islets at birth.
A 5-HT is taken up by pancreatic explants prepared from E13.5 mice. Data were expressed as means  SEM. Experiments were performed in duplicate. Scale
bar = 20 lm.
B Likewise, INS-1E cells treated for 45 min with 5-HT (5 lM) accumulate this monoamine as measured by HPLC (means  SEM; data are from duplicate
experiments).
C (left) Experimental outline to test amphetamine-induced protein serotonylation in vitro. (middle) Full-length Western blots showing total protein load upon Cy5-
labeling and 5-HT-containing proteins. Arrow points to the protein band used for quantitative analysis (right). Note that amphetamine (10 lM) when combined
with 5-HT (1 lM) eliminated the effect of the latter alone. Experiment was performed with quadruplicate biological samples. Data were expressed as
means  SEM.
D Schema with methamphetamine (10 mg/kg), amphetamine (10 mg/kg), or cocaine (20 mg/kg) injected between E14.5 and 16.5. (D1) Representative images of
neonatal tissues triple-labeled for insulin, glucagon, and 5-HT. Hoechst 33342 was used as a nuclear counterstain (pseudo-colored in gray). Scale bars = 15 lm and
6 lm (inserts). (D2) Prenatal exposure to psychostimulants does not affect either a or b cell numbers in the P0 mouse pancreas. Quantitative data from n ≥ 3
mice/group (from n = 3 pregnancies) were expressed as means  SD.
E, F In utero psychostimulant exposure significantly decreased 5-HT immunoreactivity (E). (F) Likewise, insulin immunoreactivity was reduced. Quantitative data from
n ≥ 3 mice/group (from n = 3 pregnancies) were expressed as means  SD.
G Positive correlation between insulin and 5-HT immunosignals per b cell in control and after prenatal drug exposure. Pearson correlation was defined on data from
n ≥ 60 cells/drug.
Data information: Data were analyzed by pair-wise comparisons after one-way ANOVA. ***P < 0.001, **P < 0.01, *P < 0.05.
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in both sexes (Appendix Fig S4B). These data were supported by
reduced Ins2 mRNA levels (Fig 6B).
We then asked whether the loss of insulin content affects glucose
metabolism in psychostimulant-exposed offspring. Body weights of
6-week-old mice prenatally exposed to psychostimulants did not dif-
fer from controls (Appendix Fig S4C). Nevertheless, psychostimu-
lant-exposed offspring were glucose intolerant: their blood glucose
levels were significantly higher before and during glucose challenge
for both females [P < 0.05 at 0, 30, 60, and 120 min (amphetamine)
or (cocaine); P < 0.05 at 30 min (methamphetamine) versus
(saline); Fig 6C] and males [P < 0.05 at 0, 30–120 min (am-
phetamine); P < 0.05 at 0, 60, 90, and 120 min (methamphetamine)
versus (saline); Fig 6D]. Next, we plotted the “area under the
curve” (AUC) to test for the relative severity of glucose intolerance,
which revealed a more severe phenotype in females (P < 0.05 for all
drugs; Fig 6E) than in males (P < 0.05 for amphetamine; Fig 6F).
Thereafter, we studied a 1-year-old cohort of mice prenatally
exposed to amphetamine, which appeared as the most harmful drug
at 6 weeks of age. Neither the size of (including b and a cells
numbers; Appendix Fig S4D) nor the insulin content in
amphetamine-exposed pancreata was reduced relative to their
respective controls in either sex, although amphetamine-exposed
females tended to present lower insulin immunoreactivity (Fig 6G
and G1). Female but not male mice prenatally exposed to ampheta-
mine presented with reduced bodyweight (P < 0.01, Fig 6H).
Remarkably, mice of both sexes with a history of amphetamine
exposure showed hypoglycemia at rest (Fig 6I and J). In ampheta-
mine-exposed females, the first phase of insulin release was normal.
However, its second phase was significantly blunted (Fig 6I; for
AUC calculation see Fig 6K). Amphetamine-exposed male mice
showed blood glucose levels comparable to those of controls (Fig 6J
and K). In sum, these data evidence a permanent deregulation of
glucose homeostasis in adult offspring with a history of in utero
psychostimulant exposure.
Pet1/Fev-dependent deregulation of insulin expression as a
candidate mechanism of psychostimulant action
The fact that episodic maternal intake of illicit psychostimulants
could compromise the offsprings’ glucose metabolism for life
A
B B1
A1
Figure 5. Both amphetamine and escitalopram reduce insulin immunoreactivity in female offspring at birth.
A Histochemical examples of neonatal pancreata used for the simultaneous detection of insulin and glucagon. Hoechst 33342 was used as nuclear counterstain. Scale
bars = 80 lm. (A1) Quantitative data from n > 6 mice/sex from independent pregnancies. Note that insulin immunoreactivity was significantly reduced in the
pancreas of female but not male offspring. Data were expressed as means  SEM, **P < 0.01 (pair-wise comparisons after one-way ANOVA). Figure EV4C and C1 is
referred to data on Slc6a4/ mice.
B Longitudinal cross-sectional rendering of the neonatal mouse torso to aid pancreas visualization by light-sheet microscopy. The area with semi-transparent red overly
is shown in B1. (B1) Insulin-labeled pancreata (encircled by dashed lines) from respective pairs of control and amphetamine-treated neonatal mice. Note the reduced
size and labeling intensity for insulin of pancreatic islet-like structures (arrowheads) upon intrauterine amphetamine exposure. Inset reveals that the core–shell
cytoarchitecture of an islet is retained in optically cleared intact tissues simultaneously processed for the detection of insulin and glucagon. Many peripheral organs
showed significant autofluorescence. Scale bar = 1.5 mm. Videos of orthogonally reconstructed tissues are available as part of the Appendix file.
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prompted us to examine cellular determinants of adverse drug
effects. Stimulation of 5-HT receptors on b cells has been shown to
activate Pet1/Fev, an archetypal “5-HTergic transcription factor”,
which promotes Ins1/2 expression (Ohta et al, 2011). We hypothe-
sized that psychostimulant-induced deregulation of 5-HT signaling
might reduce Pet1/Fev expression, thus rendering it insufficient to
A
B
G
H I J K
G1
C D E F
A1
Figure 6. Prenatal psychostimulant exposure impairs glucose homeostasis in adult offspring.
A, B Immunohistochemistry for insulin and glucagon in pancreatic islets of 6-week-old offspring born to drug-exposed mothers (A). Sex assignment shows that females
respond to prenatal drug exposure with permanently reduced insulin levels. (A1) Representative images from females are shown and were counterstained with
Hoechst 33342 (pseudo-colored in gray). Scale bar = 40 lm. (B) Ins2 mRNA expression remains reduced in adult offspring exposed in utero to psychostimulants
(pooled data). Quantitative data in (A, B) are from n ≥ 3 mice/group and were expressed as means  SD.
C, D Blood glucose profiles during glucose tolerance test in females (C) and males (D) at 6 weeks of age.
E, F Quantification of the “area under the curve” (AUC) indicates glucose intolerance in female mice prenatally exposed to psychostimulants with only
amphetamine-treated males showing significantly increased AUC.
G Insulin immunoreactivity no longer differed between amphetamine-exposed and control mice, irrespective of their sex, at 1 year of age. (G1) Representative
images; Scale bar = 65 lm.
H The bodyweight of 1-year-old female mice prenatally exposed to amphetamine was significantly reduced versus vehicle-treated controls.
I, J Blood glucose profiles during glucose tolerance testing in females (I) and males (J) at 1 year of age.
K AUC indicates glucose intolerance in female but not male mice prenatally exposed to amphetamine.
Data information: Quantitative data were normalized to those in control and expressed as means  SD (for visual clarity SD were omitted in C, D, I, J); n ≥ 3
animals/group/sex were analyzed (from 3 to 4 pregnancies each). ***P < 0.001, **P < 0.01, *P < 0.05 (pair-wise comparisons after one-way ANOVA).
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maintain insulin expression (Fig EV5A). In pancreatic explants,
amphetamine (P < 0.01), cocaine (P < 0.001), and metham-
phetamine (P < 0.001) significantly reduced Pet1/Fev mRNA levels
relative to controls (Fig EV5B). In contrast, 5-HT itself did not affect
Pet1/Fev expression (Fig EV5B). Simultaneously, Ins2 mRNA
expression was reduced by both psychostimulants and 5-HT
(P < 0.01 for all; Fig EV5B), suggesting a different mechanism of
action for psychostimulants (SERT engagement) and 5-HT (receptor
engagement). We then used a correlation analysis to link Pet1/Fev
and Ins2 expression at R = 0.83, P < 0.001 (Fig EV5B). At the same
time, neither psychostimulants nor 5-HT affected glucagon (Gcg)
expression significantly (Fig EV5C), which also failed to correlate
with Pet1/Fev expression (Fig EV5C1).
Next, we probed if similar changes occur upon intrauterine
psychostimulant exposure in vivo. In 6-week-old female mice, Pet1/
Fev expression was reduced upon prenatal amphetamine and
cocaine exposure (Fig EV5D) and exhibited a close correlation with
Ins1/2 mRNA levels (Fig EV5D). These data support our notion that
psychostimulants impair a transcriptional checkpoint mandatory for
insulin production in b cells.
Whether PET1/FEV might be relevant to insulin (INS) expression
in humans [beyond the animal models described here and previ-
ously (Ohta et al, 2011)] is unknown. Therefore, we used bulk
mRNA from pancreatic islets of humans stratified for glucose intol-
erance (Uhlen et al, 2005; Fadista et al, 2014), which shows that
PET1/FEV expression indeed correlated with that of INS (R = 0.41,
P = 4.7e9; Fig EV5E) and was differentially expressed between
non-diabetic and type 2 diabetic donor islets (Appendix Fig S5A and
A1). In contrast, a correlation between PET1/FEV and GCG expres-
sion did not reach statistical significance (R = 0.14, P = 0.064;
Fig EV5E), suggesting that PET1/FEV in humans is also involved in
determining physiological insulin availability. Interestingly,
SLC18A2 expression correlated positively with that of INS but not
GCG in human pancreatic islets (Appendix Fig S6A–A3). In contrast,
SLC6A4 expression showed a negative correlation with INS but posi-
tive with GCG expression (Appendix Fig S6B–B3). These data are
not unexpected since our single-cell RNA-seq analysis returned
predominant expression of SLC6A4 in human a cells (Fig EV1).
Thus, our results substantiate the cell type-specific use of monoami-
nes in human pancreatic islets.
Epigenetic changes upon intrauterine amphetamine exposure
The finding that glucose intolerance persists postnatally in
offspring exposed to psychoactive drugs in utero suggests signifi-
cant changes in the epigenetic landscape of the amphetamine-
treated pancreas. Considering the tight correlation of Pet1/Fev and
Ins expression, one might assume that Pet1/Fev repression could
directly severe insulin production. Alternatively, impairment of
upstream regulatory gene networks or effectors at the level of, e.g.,
regulated exocytosis might account for lifelong glucose intolerance.
To experimentally test these hypotheses, we first set up an in vitro
assay of chromatin accessibility: INS-1E cells were exposed to
amphetamine for 3 days followed by washout for 3 days (to
discount acute drug effects), sample preparation and ATAC-seq
(Fig 7A). This experimental design reduced Ins1 mRNA expression
(Fig 7A1). Our data showed that Ins1, Ins2, and Pet1/Fev are not
subject to changes in chromatin accessibility upon amphetamine
treatment in vitro (Fig 7A2), and argue for a more indirect regula-
tory mechanism.
Next, we studied the DNA methylation landscape in P0 pancreata
of mice of both sexes from amphetamine-treated and control dams
(Fig 7B and B1). By using methylKit (Akalin et al, 2012), we
performed independent tests with sex and amphetamine treatment
as variables. We derived six gene sets for comparisons and visual-
ized the lack of any of their intersections by UpSetR (Conway et al,
2017). This analysis returned similar results on base-pair and
promoter levels for both pooled samples and upon overdispersion
correction of covariates. Interestingly, the most prominent dif-
ferences were revealed between amphetamine-treated females
versus amphetamine-treated males, as well as between ampheta-
mine-treated males versus control males. These data suggest that
the epigenetic regulation of pancreatic cell identity and function is
critically sex-dependent and that prenatal amphetamine exposure
can significantly alter pancreatic DNA methylation. Our results also
confirmed that Ins1, Ins2, and Pet1/Fev are not affected by either
hyper- or hypomethylation (Fig 7C). Notably, we find hypomethy-
lated states of critical regulatory regions (close to the transcription
start site or promoter) in genes that specify pancreas development
(Lmx1b, Ism1) are implicated upstream to Pet1/Fev and involved in
5-HT-related pathways (Htr1a; Fig 7C1) (Mellitzer et al, 2006; Ohta
et al, 2011). Moreover, we defined sex- and amphetamine-depen-
dent changes in DNA methylation for, e.g., Gria1 (glutamate recep-
tor subunit) and Homer2 (postsynaptic scaffolding protein), which
regulate sensitivity to glutamate (Fig 7C2). Even though the sample
size of our analysis constitutes a potential confound, gene ontology
(GO) enrichment analysis (Falcon & Gentleman, 2007) of genes for
the “top 500” most perturbed promoters using amphetamine treat-
ment as variable showed differences in an unexpectedly large
number of pathways (Fig 7D), with 5-HT-related gene networks and
regulatory gene sets most severely affected. Cumulatively, these
data suggest that amphetamine permanently deregulates 5-HT
signaling and affects regulatory gene networks hierarchically placed
above Pet1/Fev and Ins to produce lifelong pancreas dysfunction.
Discussion
Glucose homeostasis is maintained by hormone release from the
endocrine pancreas. If this function is compromised, the body loses
its ability to regulate blood glucose levels, which is causal to devel-
oping diabetes mellitus (both type 1 and 2) (Roder et al, 2016).
Here, we show that prenatal exposure to the commonly abused
psychostimulants amphetamine, cocaine, and methamphetamine
leaves offsprings’ glucose homeostasis permanently impaired, lead-
ing to glucose intolerance. Earlier, cytotoxic effects of psychostimu-
lants were reported in the brain (Costa et al, 2013). However, we
show that psychostimulants at doses known to induce behavioral
effects in mice (Barenys et al, 2010; Lee et al, 2011; Khoradmehr
et al, 2015) do not modify pancreatic islet cytoarchitecture in utero.
Instead, these drugs impose functional modifications enduring into
the adulthood of affected offspring. Our findings on reduced 5-HT
signaling and Pet1/Fev expression are compatible with permanently
decreased 5-HT levels in the brains of rats prenatally exposed to
cocaine (Henderson & McMillen, 1993). However, we find that it is
not Pet1/Fev itself whose expression is directly impacted by
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psychostimulants. Instead, the many regulatory genes and archetyp-
ical transcription factors that drive pancreas specification (and
particularly b cell differentiation) undergo long-term and sex-
specific epigenetic modifications at the level of DNA methylation,
thus being poised to impose lifelong expressional deregulation of
insulin production.
A
A1
A2
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D
C1
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B1
B
Figure 7.
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The pharmacology of psychostimulant drugs is intensely studied
(Volkow & Morales, 2015), particularly because of the many “legal
highs” and synthetic compounds entering the recreational market
(Korpi et al, 2015). Even though the biological half-life of ampheta-
mine, methamphetamine (5–30 h), and cocaine (0.7–1.5 h) differs
significantly, they affect intercellular communication by monoami-
nes, with varying affinities for VMAT2 and cell-surface reuptake
transporters (NET, DAT, and SERT) (Pifl et al, 1995; Kitanaka et al,
2006; Steinkellner et al, 2014; Ross et al, 2015; Sitte & Freissmuth,
2015). The powerful psychoactive effects of these drugs warrant a
primary focus on the nervous system. Likewise, the pancreas is
another legitimate target in view of its 5-HT-, DA-, and NE-mediated
events, including paracrine communication between a and b cells,
auto-regulatory feedback for hormone release, and the sympathetic
control of hormonal output (Sorenson et al, 1979; Paulmann et al,
2009; Ustione & Piston, 2012; Borden et al, 2013; Almaca et al,
2016). Even if more indirectly, the appetite-suppressing effects of
psychostimulants (Vicentic & Jones, 2007) also suggest a relation-
ship between neural and endocrine centers defining food intake
with the pancreas being central to the peripheral control of energy
homeostasis.
By using RNA-seq, we find SERT (SLC6A4) but not NET
(SLC6A2) or DAT (SLC6A3) expressed in human pancreatic b cells,
which we confirmed in native mouse b and INS-1E cells. This
finding was functionally substantiated by [3H]5-HT uptake experi-
ments. Even if human and mouse expression profiles correspond at
many levels, we caution against the direct translation of the rodent
data because critical differences between species exist in, e.g.,
VMAT2 expression (Schafer et al, 2013). When rationalizing our
developmental biology results on 5-HT signaling, one ought to
consider that: firstly, a “5-HT signaling cassette” (i.e., coincident
expression of metabolic enzymes, VMAT2, 5-HT receptors, and
SERT) exists in developing and neonatal b cells. This is reminiscent
to the early neural organization of 5-HT signaling including the pres-
ence of SERT even before the emergence of serotonin neurons in the
brain (by gestational weeks 8 and 15, respectively) (Jacobs & Azmi-
tia, 1992). Moreover, a gradual increase in TPH expression in b cells
during pregnancy (Hill, 2017) is critical to promote cell prolifera-
tion. Secondly, we show that 5-HT signaling, while functional in
pancreatic primordia producing cell lineages during its secondary
transition, can use a variety of 5-HT receptors. Our human fetal
analysis demonstrated the expression of HTR1B/1F, HTR2A/2B/2C,
and HTR3E mRNAs during the 1st trimester. These receptors could
be precisely assigned to a and b cells by single-cell RNA-seq, which
distinguished HTFR1F (and perhaps HTFR2B) as predominant in
human b cells. This receptor diversity was confirmed by histochem-
istry, is compatible with previous findings in mouse (Ohara-Imai-
zumi et al, 2013), and corroborates HTR1F-mediated b-to-a cell
signaling in humans (Almaca et al, 2016), as well as Ca2+-depen-
dent auto-regulation of insulin release upon HTR2B or HTR3 activa-
tion (Ohara-Imaizumi et al, 2013). Thirdly, the availability of
circulating 5-HT is regulated by both fetal and maternal 5-HT
sources, the latter including transient placental 5-HT production
(Bonnin et al, 2011) from tryptophan precursors (Hill, 2017). There-
fore, we posit that the psychostimulant effects seen here could pivot
on both indirect (due to the suppression of maternal food intake,
subsequent glucose depletion, and placental deregulation) and
direct (developmental reprogramming of pancreatic islets) compo-
nents in vivo. Since psychostimulants cross the placenta (Thompson
et al, 2009), suppress SERT expression and activity, and evoke
permanent modifications to Pet1/Fev and Ins expression only in b
cells (note that none of the parameters deviated significantly in a
cells), we furnish the concept of direct reprogramming of the fetal
pancreas by (meth-)amphetamine and cocaine.
Even with SERT being a solitary molecular target for psychoac-
tive drugs, Ca2+ imaging demonstrated that their acute application
rapidly and significantly reduces glucose responsiveness in b cells.
Each drug was tested in a broad range of concentrations and exhib-
ited a dose–response relationship for the frequency of Ca2+ oscilla-
tions. Particularly for 5-HT itself, the reduced frequency of Ca2+
waves coincided with their increased amplitude, which we inter-
preted as a dynamic resetting and integration of subthreshold Ca2+
transients to produce enlarged responses. Given that Ca2+ spikes in
b cells are considered as indices of primed exocytosis, we entertain
the possibility that modulating SERT in b cells could powerfully
change the temporal dynamics of insulin release. More broadly, the
pathophysiological sign of amphetamine, methamphetamine, and
cocaine use during pregnancy was uniform with reduced insulin
content in b cells. The fact that escitalopram, a selective SERT inhi-
bitor, as well as genetic Slc6a4 ablation in mice reminisced amphe-
tamine effects suggests a direct SERT involvement rather than, e.g.,
the allosteric modulation of 5-HTR1A or 5-HTR1B (Borycz et al,
2008). This is also conceivable for our in vitro studies in which bath
superfusion of the drugs could have limited the buildup of extracel-
lular 5-HT and rendered the engagement of 5-HT auto-receptor
mechanisms less prominent.
◀ Figure 7. Epigenetic changes upon amphetamine treatment in vitro and in vivo.A Experimental design and (A1) expressional quality control (note reduced Ins1 mNRA levels) in INS-1E cells treated with amphetamine. Data were expressed as
means  SD; n = 3; *P < 0.05 (Student’s t-test). (A2) Genome browser plot showing ATAC-seq average signal intensity for Ins1, Ins2, and Pet1/Fev between control and
amphetamine-treated INS-1E cells.
B UpSet plot showing intersections of gene sets obtained independently by v2-test with 0.01 Q-value cutoff. Blue triangles show events nearest to transcription start
sites (TSSs), while red triangles highlight treatment-only-related difference on B (and B1) plots. (B1) The distribution of DNA methylation differences of locus (BP) to
related variables (left to right: number of Gene Ontology (GO) terms for gene, distance to nearest TSS, mean presence of GO term (differentially methylated to the
whole size of term ratio) relevant for gene-related locus) is shown.
C Differences in DNA methylation in neonatal mice (n = 6 for control; n = 5 for amphetamine) for Ins1, Ins2, and Pet1/Fev (C), as well as Lmx1b, Htr1a, Insm1 (central to
5-HT signaling; C1). (C2) Sex differences in DNA methylation for Gria1 and Homer2 (prototypic for glutamate signaling). Interactive genome browser tracks for all
genes detected are available at the UCSC portal (http://bit.ly/AMPHpanDifMeth).
D The most enriched GO terms associated with the top 500 hypermethylated (top) and hypomethylated (bottom) promoters of amphetamine-treated versus control
mice based on the RnBeads 2.0 pipeline (Muller et al, 2019). Red color indicates the pathways associated with 5-HT signaling. Complete datasets of differential
methylation analysis for genes and promoters, as well as for sex and amphetamine effects, are available as Tables EV1–EV5.
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In utero psychostimulant exposure rendered hormonal output
from the endocrine pancreas deficient in affected offspring. This is
not unexpected with experimental evidence on epigenetic modifi-
cations mounting for the most common illicit drugs (Dinieri et al,
2011; Robison & Nestler, 2011). Particularly for maternal (meth-)
amphetamine abuse during pregnancy, female rather than male
offspring exhibit severe deficits in both people (Kogachi et al,
2017) and animal models (Castner & Becker, 1996). Histone
serotonylation emerges as a novel epigenetic mechanism, which
was shown to limit cell differentiation (Farrelly et al, 2019). Thus,
fetal deregulation of intracellular 5-HT availability by psychostimu-
lants could contribute to the developmental delay for b cells,
which is supported by the reduction of NeuroD1 and Nkx6.1 tran-
scription factors in our animal models. Indeed, we found long-lived
intracellular 5-HT accumulation upon 5-HT loading of both pancre-
atic explants and INS-1E cells, which was occluded by ampheta-
mine. A plausible explanation for this phenomenon is that 5-HT
became covalently bound to glutamine residues of proteins in a
reaction catalyzed by transglutaminases. A lifelong change in
SERT-mediated 5-HT loading could become of pathological signifi-
cance because residual 5-HT executes rate-limiting feedback for
insulin secretion by serotonylation of, e.g., Rab3a and Rab27a
GTPases (Paulmann et al, 2009), critical for SNARE assembly and
the priming of vesicle docking. Considering that DNA hypermethy-
lation was most common amongst genes assigned to 5-HT release
by GO pathway analysis, and 5-HT is co-released with insulin from
mature b cells (Suckale & Solimena, 2010), we favor the hypothe-
sis that reduced protein serotonylation links adverse psychostimu-
lant effects to epigenetic modifications persisting throughout life in
b cells of affected offspring.
In sum, we identify a pathological principle by linking maternal
psychostimulant abuse during pregnancy to impaired glucose home-
ostasis throughout life. Considering the continued rise in the
consumption of illicit drugs by young adults, including women of
child-bearing age, we warn against gestational exposure to “5-HT
modifying drugs”, such as amphetamines and cocaine, to minimize
harm to the unborn fetus.
Materials and Methods
Gene expression analysis in human subjects
Tissue biopsies from terminated foetuses (7–14 gestational weeks)
were used to describe mRNA expression patterns for monoamine
signaling systems in fetal pancreata (Fig 1). DNA and RNA were
extracted using the TRIZOL method (Life Technologies) with quality
control performed on an Agilent 2200 Tapestation system (Bio-Rad)
and quantification using Qubit. RNA libraries were then constructed
using the TruSeq RNA library preparation kit (Illumina). RNA
sequencing was performed on a HiSeq 2000 system (Illumina).
Paired-end 101 bp-long reads were aligned to the Reference Human
Genome Build 37 using STAR. Gene expression was measured as
the normalized sum of expression of all exons. The “dexseq_count”
python script (http://bioconductor.org/packages/DexSeq/) was
used to count uniquely mapped reads in each exon. Gene and exon
expression normalizations were then performed using the TMM
method in edgeR.
Gene–type 2 diabetes relationships were studied in islets from
202 cadaver donors of European ancestry (Nordic Islet Transplan-
tation Programme; http://www.nordicislets.org). All procedures
were approved by the ethics committee at Lund University and
performed as described (Fadista et al, 2014). Briefly, purity of the
islets was assessed by dithizone followed by islets culture in CMRL
1066 (ICN Biomedicals) supplemented with 10 mM HEPES, 2 mM
L-glutamine, 50 lg/ml gentamicin, 0.25 lg/ml fungizone (Gibco),
20 lg/ml ciprofloxacin (Bayer Healthcare), and 10 mM nicoti-
namide at 37°C (5% CO2) for 1–9 days prior to RNA preparation.
Total RNA was isolated with the AllPrep DNA/RNA Mini Kit (Qia-
gen). RNA quality and concentration were measured using an
Agilent 2100 bioanalyzer (Bio-Rad) and a Nanodrop ND-1000
(NanoDrop Technologies), respectively. Samples were stratified
based on glucose tolerance estimated from HbA1c, i.e., donors
with normal glucose tolerance (HbA1c < 6%, n = 123), impaired
glucose tolerance (IGT, 6% ≤ HbA1c < 6.5%, n = 47), and type 2
diabetes (HbA1c ≥ 6.5%, n = 32). A linear model adjusting for age
and sex as implemented in the R Matrix eQTL package was used
to determine the expression of genes associated with glucose toler-
ance status. Raw data were base called and de-multiplexed using
CASAVA 1.8.2 (Illumina) before alignment to hg19 with STAR. To
count the number of reads aligned to specific transcripts, feature-
Counts (version 1.4.4, http://bioinf.wehi.edu.au/featureCounts/)
was used. Raw data were normalized using trimmed mean of
M-values (TMM) and transformed into log2 counts per million
(log2CPM) using voom (limma R, Bioconductor) before linear
modeling. After TMM normalization, batch effects were removed
using the Combat function (sva package).
Single-cell RNA-seq of pancreatic islets
Analysis was performed based on a publicly available expression
matrix (Segerstolpe et al, 2016) from 270 human b cells and 874
human a cells from 6 healthy and 4 type 2 diabetic donors, which
was originally generated on human tissue and primary islets from
Prodo Laboratories Inc., providing islets isolated from donor pancre-
ata obtained from deceased individuals with research consent from
Organ Procurement Organizations. Single-cell RNA-seq libraries
were produced with the Smart-seq2 protocol (Segerstolpe et al,
2016). Sequencing was carried out on an Illumina HiSeq 2000 gener-
ating 43 bp single-end reads. Sequence reads were aligned toward
the human genome (hg19 assembly) using STAR (v2.3.0e), and
uniquely aligned reads within RefSeq gene annotations were used to
quantify gene expression as RPKMs using the “rpkmforgenes”
routine (http://sandberg.cmb.ki.se/rnaseq/).
Mice
On embryonic days (E) 14.5, 15.5, and 16.5, pregnant C57BL/6N
mice (Charles River) were intraperitoneally injected with ampheta-
mine (n > 10; 10 mg/kg body weight), methamphetamine (n = 6;
10 mg/kg body weight), cocaine (n = 6, 20 mg/kg body weight), or
saline (n > 10; as control) at an injection volume of 10 ml/kg. All
drugs were obtained from Sigma. Wild-type (Slc6a4+/+) and pheno-
typically Slc6a4 null fetuses on a C57BL/6J background were
generated by mating heterozygous Slc6a4-Cre+/ knock-in mice
(B6.129-Slc6a4tm1(cre)Xz/Cnrm; strain EM:04890 from the European
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Mouse Mutant Archive) with Cre+/+ predicted to completely
disrupt Slc6a4 function (n = 4 dams; Appendix Fig S3). Only wild-
type and null littermate offspring were analyzed after daily in utero
exposure to amphetamine (E14.5–E16.5). On P0, offspring in each
litter was randomly chosen and sacrificed for analysis. This was
done such that each litter was kept equal in size until weaning.
Animals were kept in groups of 6 under standard housing conditions
with a 12-h/12-h light/dark cycle and food and water available ad li-
bitum. Experiments on live animals conformed to the 2010/63/EU
European Communities Council Directive and were approved by the
Austrian Ministry of Science and Research (66.009/0145-WF/II/3b/
2014, and 66.009/0277-WF/V/3b/2017). Particular effort was
directed toward minimizing the number of animals used and their
suffering during experiments.
GTT assay
Six-week-old offspring prenatally treated with amphetamine (five
females; 11 males), methamphetamine (three females; 13 males),
cocaine (eight females; six males), and saline (11 females; five
males) from 3 to 4 pregnancies/drug, as well as 1-year-old mice
exposed to amphetamine (six females; five males) or saline (five
females; three males) in utero were analyzed. Animals were fasted
overnight (~15 h) with water available ad libitum. Blood glucose
levels were measured from tail blood using a FreeStyle Lite glucose
meter (Abbott Diabetes Care) before (baseline, 0 min), as well as
15, 30, 60, 90, and 120 min after i.p. glucose challenge (2 g/kg).
Data were expressed as mg/dl blood glucose and analyzed as “area
under curve (AUC)”, a descriptor representative of overall change
during the sampling period.
Isolation of pancreatic islets
Islets were obtained after perfusion of the pancreas with Hank’s
balanced salt solution (HBSS; Invitrogen/Gibco) containing collage-
nase (type I, 0.33 mg/ml; Sigma) and HEPES (25 mM), followed by
purification on Histopaque 1,077 gradients (Sigma) (Szot et al,
2007). After repeated washes in HBSS containing 10% fetal bovine
serum (FBS), isolated islets were maintained in RPMI-1640 medium
supplemented as above in humidified atmosphere (5% CO2) at 37°C
overnight prior to measuring hormone release.
Organotypic cultures of embryonic pancreata
Dorsal pancreatic buds were dissected on E13.5 under a stereo-
scope and cultured on 0.4 lm pore-sized filters (Millicell-CM;
Millipore) in DMEM (Gibco) supplemented with N2 (Gibco) and
streptomycin–penicillin–glutamine (Gibco) (Serafimidis et al,
2017). Equivalent to E14.5, E15.5, and E16.5 (i.e., 1–3 days
in vitro (DIV)), explants were transferred to fresh medium that
had optionally been supplemented with amphetamine (10 lM),
cocaine (10 lM), methamphetamine (10 lM), or 5-HT (0.5 lM;
Tocris). On DIV4, all explants were transferred to fresh medium
and cultured for 2 more days. Culture media were then collected
with explants either fixed for immunohistochemical analysis or
snap frozen for gene expression profiling. Quantitative analysis
was performed using ImageJ1.45 with appropriate plug-ins on
n = 4–6 explants/group.
RNA isolation and gene expression analysis
Total RNA from P0 pancreata, as well as adult pancreatic islets, was
isolated using the Aurum Total RNA Mini Kit (Bio-Rad) followed by
DNase digestion. cDNA was prepared by reverse transcription with
random primers using a High-capacity cDNA Reverse Transcription
Kit (Applied Biosystems). Quantitative PCR analysis (CFX Connect,
Bio-Rad) was performed using 50 ng of cDNA template, iTaq
Universal SYBR Green Supermix (Bio-Rad), and specific primer pairs
(Table 1).
Table 1. Primer sequences used for quantitative analysis in this
study.
Gene Primer sequence Species
Gapdh Forward: 50-AACTTTGGCATTGTG-30 Mouse
Reverse: 50-ACACATTGGTAG-30
Gcg Forward: 50-TACACCTGTTCGCAGCTCAG-30 Mouse
Reverse: 50-CTCTGTGTCTTGAAGGGCGT-30
Gcg Forward: 50-AGGAACCGGAACAACATTGC-30 Rat
Reverse: 50-CCTTTCACCAGCCAAGCAAT-30
Htr2b Forward: 50-TGTTTGTGATGCCGATTGCC-30 Mouse
Reverse: 50-AGTTGCACTGATTGGCCTGA-30
Ins1 Forward: 50-CCACCCAGGCTTTTGTCAAA-30 Mouse
Reverse: 50-CCAGTTGTTCCACTTGTGGG-30
Ins1 Forward: 50-GTGGGGAACGTGGTTTCTTC-30 Rat
Reverse: 50-TGCAGCACTGATCCACAATG-30
Ins2 Forward: 50-CCACAAGTGGCACAACTGGA-30 Mouse
Reverse: 50-CTACAATGCCACGCTTCTGC-30
Ins2 Forward: 50-GTGACCAGCTACAGTCGGAA-30 Rat
Reverse: 50-GAGCTTCCACCAAGTGAGAAC-30
NeuroD1 Forward: 50-GCTCCAGGGTTATGAGATCGT-30 Mouse
Reverse: 50-CATCTGTCCAGCTTGGGGGA-30
Nkx6-1 Forward: 50-GCACGCTTGGCCTATTCTCT-30 Mouse
Reverse: 50-GAAGTCCCCTTGAGCCTCTC-30
Pet1/Fev Forward: 50-AGATCCCGTCGGAGATGGTC-30 Mouse
Reverse: 50-GGTCGGTGAGCTTGAACTCG-30
Pdx1 Forward: 50-ACTTAACCTAGGCGTCGCAC-30 Mouse
Reverse: 50-AGCTCAGGGCTGTTTTTCCA-30
Slc6a4 Forward: 50-GGCGCGAGGGTCGAG-30 Mouse
Reverse: 50-ATGCTGGTCAGTCAGTG-30
Tbp Forward: 50-ACCCCTTCACCAATG
ACTCCTATG-30
Mouse
Reverse: 50-ATGACTGCAGCAAATCGCTTGG-30
Tbp Forward: 50-ACAGCCTTCCACCTTATGCT-30 Rat
Reverse: 50- GCTGCTGTCTTTGTTGCTCT-30
Tph2 Forward: 50-TCTACACCCCGGAACCAGAT-30 Mouse
Reverse: 50-GCAAAGGCCGAACTCGATTG-30
qPCR products were performed with primer pairs amplifying short fragments
for each gene. Primer pairs were custom-designed to efficiently anneal to
homologous nucleotide sequences from mouse.
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HEK293 cells, transfection, and maintenance
Human embryonic kidney (HEK) 293 cells were grown in minimum
essential medium with Earle’s salts and L-glutamine, 10% heat-inac-
tivated FBS, and gentamicin (50 mg/l; all from Sigma). Cells were
typically grown in 60- or 100-mm tissue culture plates (polystyrene,
Falcon) at 37°C in 5% CO2 atmosphere. The human SERT (SLC6A4)
was stably expressed using a pRc/CMV vector (Thermo Fisher; Ca-
phosphate transfection) followed by selection with G418 (1 mg/ml)
as described (Pifl et al, 1996).
Tissue preparation and immunohistochemistry
Adult mice were transcardially perfused with ice-cold 0.1 M Na-
phosphate buffer (PB), followed by 4% paraformaldehyde (PFA)
in PB (100 ml at 3 ml/min flow speed). Pancreata were rapidly
dissected and post-fixed in 4% PFA overnight. P0 mice were
sacrificed with their torsos immersion fixed in 4% PFA overnight.
After equilibrating in 30% sucrose for 48–72 h, tissues were
cryosectioned at either 14 lm (adult and P0) or 8 lm (E14.5)
thickness (Leica CM1850) and thaw-mounted onto SuperFrost+
glass slides. After rinsing in 0.1 M PB, specimens were exposed
to a blocking solution composed of 0.1 M PB, 10% normal
donkey serum, 5% BSA, and 0.3% Triton X-100 for 3-h followed
by 48-h incubation with select combinations of primary antibodies
(Table 2). Carbocyanine (Cy)2,3 or 5-conjugated secondary anti-
bodies (1:300, Jackson ImmunoResearch) were applied in 0.1M
PB supplemented with 2% BSA (20–22°C, 2 h). Nuclei were routi-
nely counterstained with Hoechst 33342 (1:10,000; Sigma). Histo-
chemical detection of Pdx1 required antigen retrieval, e.g.,
incubating glass-mounted sections in 1× target retrieval solution
(pH 6.0, Dako) at 95°C for 15 min followed by repeated washes
in 0.1 M PB. Sections were coverslipped using Fluoromount aque-
ous mounting medium (Sigma). Tissues were photographed on a
Zeiss LSM880 laser-scanning microscope equipped with a Plan-
Apochromat 20×/air objective at 1.0–2.5× optical zoom. Images
were acquired in the ZEN2010 software package. Quantitative
analysis was performed using ImageJ1.45 with appropriate plug-
ins on n ≥ 3/group with n = 8–10 islets per animal analyzed.
Multi-panel images were assembled in CorelDraw X7 (Corel
Corp.).
Optical tissue clearing and light-sheet microscopy
Pancreata were excised en bloc, repeatedly washed in PB, and opti-
cally cleared by immersion in “CUBIC reagent 1” (25% urea, 25%
N,N,N0,N0-tetrakis(2-hydroxypropyl)ethylenediamine and 15%
Triton X-100) for 1 week (Susaki et al, 2014). Insulin immunohisto-
chemistry was performed by first blocking the specimens in 2%
BSA, 5% NDS in 0.1M PB for 3–6 h, and then exposing the speci-
mens to rabbit anti-insulin antibody (1:450; Table 2) in 0.1% BSA,
2% NDS, 5% DMSO, and 0.3% Triton X-100 on an orbital shaker at
37°C for 7 days. This incubation step was followed by repeated
rinses in 0.1M PB with subsequent exposure to Cy2-conjugated
secondary antibody raised in rabbit (1:400; Jackson) at 37°C for
5 days. Samples were then rewashed in PB and submerged in
“CUBIC reagent 2” (50% sucrose, 25% urea, 10% 2,20,200-nitrilo-
triethanol, and 0.1% Triton X-100) for further clearing (additional
5–8 days). Cleared tissues were imaged in “CUBIC reagent 2” with a
measured refractory index of 1.45 orthogonal on a Lightsheet Z.1
(Zeiss) microscope using a 5× detection objective, 5× illumination
optics, and laser excitation at 488 nm. Each plane was illuminated
from a single side with images captured at 0.9× optical zoom at 3.5-
lm z-stack intervals and an exposure time of 150 ms. Three-dimen-
sional-rendered images were visualized with Arivis Vision4D for
Zeiss (v. 2.12). Brightness and contrast of the images were manually
adjusted to aid visual clarity. Quantitative analysis was performed
in Arivis. Optionally, tissue clearing involved the simultaneous
detection of insulin (1:500; Dako) and glucagon, with mouse anti-
glucagon (1:500; Sigma) and Cy3-conjugated donkey anti-mouse
used as secondary antibody (1:400; Jackson) for the latter.
High-performance liquid chromatography
INS-1E cells were seeded at a density of 650,000 cells/well in 6-well
plates and serum starved overnight. Subsequently, cells were
exposed to 5-HT (5 lM) for 45 min (in duplicate). After washing in
ice-cold 0.05 M phosphate-buffered saline (2×), samples were
scraped into 300 ll of perchloric acid and Na-bisulfite (final concen-
trations are 0.1 M and 0.4 mM, respectively), ultrasonicated, and
centrifuged at 16,100 g for 10 min. For the determination of intracel-
lular 5-HT levels, 100 ll supernatant was injected directly into a
HPLC system equipped with a LiChroCART 250-4 column (RP18l,
5 lm, VWR) and a BAS electrochemical detector (Bioanalytical
System). The mobile phase consisted of 0.1 M sodium acetate buffer
(pH 4.3) containing 1 mM EDTA, 0.2 mM l-heptane sulfonic acid,
0.1% triethylamine, 0.2% tetrahydrofuran, and 10% methanol.
Table 2. List of antibodies used in this study.
Antibody Source Concentration Supplier & Cat. No.
5-HT Rabbit 1:100 (IHC) Dr. T.F. Görcsa
1:400 (WB)
5-HTR1A Rabbit 1:65 (IHC) Atlas/Sigma, #HPA018073
5-HTR1F Rabbit 1:50 (IHC) Atlas/Sigma, #HPA005555
Β-Actin Mouse 1:2,000 (WB) US Biological, #A0760-40
Glucagon Mouse 1:2,000 (IHC) Sigma, #G2654
Insulin Guinea
pig
1:500 (IHC) DAKO, #A0564
Mouse 1:500 Cell Signaling, mAb#8138
Rabbit 1:450 Cell Signaling, mAb#3014
PDX1 Rabbit 1:500 Cell Signaling, mAb#5679
SERT Guinea
pig
1:100 (IHC) Chemicon, #AB1772
1:500 (WB) Santa Cruz, #sc-1458
TPH2 Rabbit 1:100 Atlas/Sigma, #HPA046274
5-HT, 5-hydroxytryptamine (serotonin); 5-HTR1A, 5-hydroxytryptamine
receptor 1A; 5-HTR1F, 5-hydroxytryptamine receptor 1F; PDX1, pancreatic and
duodenal homeobox 1; SERT; Serotonin transporter; TPH2, Tryptophan
hydroxylase 2.
Commercially available primary antibodies (except for 5-HT) were used for
immunohistochemistry. Vendors and catalogue numbers (Cat. No.) are given
for reasons of reproducibility.
aDr. Tamás F. Görcs (formerly of Semmelweis University, Budapest Hungary)
passed away on 14.01.2014.
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Radiolabeled ligand uptake and associated pharmacology
INS-1E cells were seeded at a density of 250,000 cells/well in 24-
well plates and incubated with 0.3 lM [3H]5-HT, [3H]DA, or [3H]NE
(all from Perkin Elmer) in uptake buffer with/without escitalopram
(10 lM; SERT inhibitor) or mazindol (10 lM, Novartis; dual DAT/
NET inhibitor) at 37°C for 5 min. To test whether VMAT2 is opera-
tional and contributes to amphetamine effects in INS-1E cells, we
exposed samples (250,000 cells/well grown for 3 days in vitro) to
0.1 lM [3H]5-HT in uptake buffer containing 3, 6, or 15 mM D-
glucose in the absence or presence of reserpine (300 nM, Sigma; a
VMAT2 inhibitor) or escitalopram (10 lM, Sigma; SERT inhibitor)
at 37°C for 45 min. Intracellular [3H] was measured in a scintillation
counter (Beckman) and considered as a 1:1 indicator of cate-
cholamine content.
Ca2+ imaging
Ca2+ responses of INS-1E cells were recorded using Fura-2AM
(Invitrogen). Ratiometric imaging (Malenczyk et al, 2017) was
performed by using a VisiChrome monochromator (Visitron
Systems), and CoolSnap HQ2 back-cooled camera (Photometrics)
mounted onto a Zeiss Axiovert microscope equipped with a water-
immersion 20×/differential interference contrast objective (Plan-
Apochromat/N.A. 1.0). Ca2+ responses were recorded using the
VisiView software (Visitron Systems) and evaluated in GraphPad
Prism 7 (GraphPad). Measurements were performed in standard
Krebs-Ringer basic external solution containing (in mM): 119 NaCl,
2.5 KCl, 1 NaH2PO4, 1.5 CaCl2, and 1.5 MgCl2, 20 HEPES, and
“high” (11) or “low (3) glucose (pH 7.4). Drugs were directly
applied into the recording chamber at the final concentrations indi-
cated. Experiments were performed at 25°C.
In vitro electrophysiology
HEK293 cells at a density of 1.5 × 104 were split onto poly-D-lysine-
coated glass coverslips (12 mm in diameter) 48 h prior to electro-
physiological recordings. HEK293 cells were kept in Krebs-Ringer
solution that served as external solution with a composition (in
mM): 119 NaCl, 2.5 KCl, 1 NaH2PO4, 1.5 CaCl2, and 1.5 MgCl2, 20
HEPES, 11 glucose (pH 7.4). For whole-cell recordings, patch
pipettes were pulled from borosilicate glass with a programmable
Flaming-Brown micropipette puller (P-100; Sutter Instruments),
heat-polished to a final tip resistance of 4–5 MO, and filled with (in
mM): 140 KCl, 2 MgATP, 0.5 EGTA, and 10 HEPES (pH 7.4 was
adjusted with kOH). Whole-cell currents were recorded by clamping
the cells at 70 mV holding potential and continuously superfused
with either bath or drug-containing solutions (25 lM amphetamine,
10 lM cocaine, 5 lM methamphetamine, or 10 lM escitalopram)
through a peristaltic pump at a flow rate of 2 ml/min. Recordings
were made on an EPC-10 triple amplifier controlled by PatchMaster
2.80 (HEKA) at 25°C. Traces were filtered and analyzed off-line
using ClampFit (Axon Instruments).
Quantitative Western blotting with total protein normalization
Total protein labeling was initiated by adding Cy5 dye reagent (GE
Healthcare) that had been pre-diluted (1:10) in ultrapure water.
Samples were mixed and incubated for 5 min at 21–24°C. The label-
ing reaction was terminated by adding Amersham WB loading
buffer (GE Healthcare; 20 ll/sample) containing 40 lM DTT.
Samples were then boiled at 95°C for 3 min with equal amounts
(20 lg/40 ll) and subsequently loaded onto an Amersham WB gel
card (13.5%). Electrophoresis (600 V, 42 min) and protein transfer
onto polyvinylidene-difluoride membranes (100 V, 30 min) were at
default settings in an integrated Amersham WB system (GE Health-
care) for quantitative SDS–PAGE and Western blotting of proteins
with fluorescence detection. After blocking, membranes were incu-
bated with rabbit anti-5HT antibody (1:400, kindly provided by T.J.
Go¨rcs) overnight. Antibody binding was detected by using species-
specific (anti-rabbit) Cy3-labeled secondary antibodies (1:1,000; GE
Healthcare). Membranes were dried before scanning at 560 nm exci-
tation. Automated image analysis was performed with the Amer-
sham WB evaluation software with manual optimization if
necessary.
Chromatin accessibility by ATAC-seq
Open chromatin mapping was performed with the assay for
transposase accessible chromatin (ATAC-seq) (Buenrostro et al,
2015) with minor modifications (Rendeiro et al, 2016). In each
experiment, 1 × 105 INS-1E cells were incubated in the trans-
posase reaction mix (12.5 ll 2× TD buffer, 2 ll TN5 transposase
(Illumina), 0.1% NP-40, and 10.25 ll nuclease-free water) at
37°C for 30 min. After DNA purification with the MinElute kit
(Qiagen), 1 ll of the eluted DNA was used in a qPCR product to
estimate the optimum number of amplification cycles. Library
amplification was followed by SPRI size selection to exclude
fragments larger than 1,200 bp. DNA concentration was
measured with a Qubit fluorometer (Life Technologies). Sequenc-
ing was performed on an Illumina HiSeq 3,000/4,000 instrument
in single-end 50 bp mode. Raw sequencing data were processed
by atacseq NextFlow pipeline (Dockerfile v.1.0.0) to perform
library-level quality control and analysis. Merged bigWigs were
normalized, peaks called, consensus sets created, counted, and
processes for differential accessibility. Interactive genome browser
tracks are available at the UCSC portal (http://bit.ly/AMPHpa
nDifMeth).
DNA and RNA extraction from frozen pancreas tissues
Pancreas samples were homogenized by using a TissueLyser II (Qia-
gen) with the following settings: 4 × 30 s, 30 Hz with RNAse/
DNAse-free ceramic beads. Tissues were dissolved in RLT lysis
buffer of the DNA/RNA Allprep Kit (Qiagen) following the manufac-
turer’s instructions. DNA quality (fragmentation) was checked on
an 0.8% agarose gel.
DNA methylation
Extracted DNA was subjected to the reduced representation bisul-
fite sequencing (RRBS) workflow as described previously
(Klughammer et al, 2018). One hundred ng of DNA was digested
at 37°C for 12 h with 20 units of MspI and TaqI (New England
Biolabs) in 30 ll of 1× NEB buffer 2. Fill-in and A-tailing were
performed by addition of Klenow fragment 30 > 50 exo- (New
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England Biolabs) and dNTP mix (10 mM dATP, 1 mM dCTP, 1 mM
dGTP). After ligation to methylated Illumina TruSeq LT v2 adaptors
using Quick Ligase (New England Biolabs), the libraries were size
selected by performing a 0.75× cleanup with AMPure XP beads
(Beckman Coulter). The libraries were pooled in equal amounts
based on qPCR data and bisulfite converted using the EZ DNA
Methylation Direct Kit (Zymo Research). Bisulfite-converted
libraries were enriched, and quality control was performed using
Qubit dsDNA HS (Life Technologies). Fragment length was assessed
using high-sensitivity DNA chips on a Bioanalyzer 2000 (Agilent).
Sequencing was performed on an Illumina HiSeq 3,000/4,000
instrument in single-end 50 bp mode. Raw fastq files were
processed within the NextFlow methylseq pipeline (Dockerfile v.1.3)
with –aligner bismark –singleEnd –genome mm10 –rrbs parameters
to obtain methylation coverage. Next, RnBeads (Muller et al, 2019)
were used for quality control and initial analysis of the DNA methy-
lation data according to established practices (Bock, 2012). We
summarized CpGs in 1,000 kb bins and performed differential DNA
methylation analysis between amphetamine treatment (n = 5)
versus control (n = 6) or male (n = 5) versus female (n = 6) data-
sets using limma (Ritchie et al, 2015) (FDR-adjusted P-value < 0.05,
fold change > 1.5, absolute difference > 25 percentage points). The
relative over-representation of hypermethylated and hypomethy-
lated tiles was used for GO pathway enrichment analysis (Falcon &
Gentleman, 2007). Additionally, we performed base-pair level and
region level (for promoters) analysis using methylKit (Akalin et al,
2012) on Bismark methylation call output files. We used both
Fisher’s exact test on pooled samples and the v2 test with overdis-
persion correction on covariates (sex or treatment factor) to inde-
pendently compare sample sets against examined factors
(Wreczycka et al, 2017). To show a lack of intersections, we visual-
ized six sets of comparisons and CpG island relatedness for all
obtained methylation events with UpSetR (Conway et al, 2017).
Statistics
All experiments were performed in triplicate unless stated other-
wise. Data were expressed as means  SD or means  SEM (as
indicated). Fold changes represent the percentage change from the
mean control value in individual experiments. A P-value of < 0.05
was considered statistically significant. Except for analysis of sex
differences in 6-week-old animals (histochemistry, GTT, and body
weight), all samples were pooled. Differences between treated (am-
phetamine, methamphetamine, cocaine) and control groups were
analyzed using one-way ANOVA (post hoc pair-wise comparison).
Data from Ca2+-imaging experiments were statistically assessed by
paired Student’s t-test. Pearson correlation was used to assess link-
age between pairs of parameters.
Data availability
Interactive genome browser tracks for all genes detected (DNA
methylation/RRBS analysis) are available at the UCSC portal
(http://bit.ly/AMPHpanDifMet) as well as in GEO (accession no.
GSE140072).
Expanded View for this article is available online.
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